Alterations in BMPR2 signaling have been shown to affect the microtubules, which is thought to contribute to the pathology of several diseases including hereditary spastic paraplegia, Huntington’s disease, and pulmonary arterial hypertension [19–21, 39]. This evidence concerns the gene BMPR2 and juvenile Huntington disease.